Predictive
Customizable
SERVICES
3D in vitro drug efficacy
ScreenIn3D offers services to miniaturize and upscale generation of 3D translational in vitro models and to test drug effects, quantifying a panel of assay specific readouts. Our models reproduce the complexity of the tumour microenvironment whilst our versatile lab-on-a-chip technology replicates in vivo dynamic conditions. We guide and support our clients to generate the most relevant disease model, define together the most appropriate assay conditions and we deliver results
3D MODEL DEVELOPMENT CO-CULTURES
Simulate cell–cell interactions and quantify cell-drug responses at scale.
Using patient-derived tissue, we generate tumoroids and complex 3D in vitro models that are rich in diverse cell types to evaluate compound effects across a range of biological systems—ideal for early and late-stage drug development using translational models.
CUSTOM ASSAY DESIGN
Tailored to your study goals.
We collaborate closely with you to build assays that reflect real disease complexity. Sequential cell seeding allows time-dependent modeling, while our UpScale3D platform supports long-term culture and scalable drug testing across many 3D models.
SINGLE & COMBO DRUGS
Evaluate your compound alone or in combination.
From standard therapies to novel agents, we mimic clinical dosing protocols in vitro. We also offer multi-format combination screening, including chemo- and radio-therapy regimens.
PARTNERSHIPS
We work with institutes and CROs to provide bespoke support and create synergies with our service. Are you interested in working with us?
